New Tool for the Early Detection of Breast Cancer

An EU-funded study has demonstrated a new technique that could be used for the early detection of breast cancer. Scientists from Finland, France and Germany used three-dimensional X-ray analysis to obtain a high-resolution, high-contrast image of the breast that is extremely sensitive to changes in the tissue, such as those that might be caused by a tumour. Their findings mark a significant improvement in the state of the art of X-ray mammography.

Breast cancer, which forms in tissues of the breast (typically the milk ducts and milk-producing glands), is the second most common type of cancer after lung cancer and the fifth most common cause of cancer death. It is widely recognised that the early detection of breast cancer is directly linked to successful treatment of the disease.

Diagnostic mammography and CT (computed tomography) scans are typically used to screen for tumours in the breast. However, the resulting images are often unclear: X-ray mammography fails to identify approximately 10 to 20 percent of palpable breast cancers. The current study found that sharper, higher-contrast images could be attained using high-spatial-resolution, low-dose, analyser-based X-ray CT imaging, also referred to as ABI.

The researchers examined an excised human breast tumour. The tissue they looked at had been invaded by a diffusely growing cancer called a lobular carcinoma, the second most common form of breast cancer. The extension of this kind of cancer is frequently missed by X-ray mammography and ultrasound. They compared ABI scans of the tissue with those from diagnostic mammography, conventional CT and histopathology. ABI provided exceptional clarity, distinguishing more microcalcifications (small deposits of minerals indicating the presence of cancer) than the other radiography methods.

The success of ABI in producing high-contrast images where the tissue is smooth and variations subtle is remarkable. "Calcifications and fine details of soft tissue, which are at the contrast detection limit on diagnostic mammograms, are clearly visible on planar analyser-based X-ray images," explains Jani Keyriläinen of Turku University Central Hospital in Finland and the main author of the paper. "If we compare the images with X-ray mammograms and conventional CT images, we can confirm that this technique performs extremely well."

The visualisation was achieved using a dose of radiation similar to that used in a normal mammography examination, and the spatial resolution of the images was estimated by the researchers to be seven times better than that achieved by a conventional CT scanner.

The improved visibility offered by ABI has implications for the early diagnosis of breast cancer. However, further investigations are needed to make this valuable diagnostic method available for clinical applications.

Dr Alberto Bravin of the European Synchrotron Radiation Facility said, "The technique does not require sophisticated and expensive synchrotron radiation facilities... [However,] it would not be viable to use X-ray tubes, as exposure times would be too long and this would be incompatible with clinical practice."

The research team hopes that the development of compact, highly intense X-ray sources will enable the clinical use of ABI. Dr Bravin commented, "With these machines it would definitely be possible to apply this technique to clinical practice and, in this way, contribute actively to a more efficient detection of breast cancer."

EU support for the study came from the PHASY (Phase analyzer system for novel imaging modalities) project, which was financed under the "Improving human research potential and the socio-economic knowledge base" Horizontal Programme of the Fifth Framework Programme (FP5).

For further information, please visit:

Copyright ©European Communities, 2008
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...